Search

everythinglearnresearchcommunity

for

Search:↓

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Testosterone and finasteride raise insulin and zinc, lower chromium in male rats.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

A postmenopausal woman's excess male hormone symptoms were caused by a rare adrenal gland tissue in her ovary.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Women with acne have lower levels of a specific hormone marker than women without acne.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Testosterone applied to rabbit skin increases skin cell growth and changes skin structure.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Testosterone increases hamster hair growth; cyproterone acetate reduces it.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

AMT may cause hair loss and changing dWAT activity could help treat it.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Inflammation may play a role in causing androgenetic alopecia.

Altered DHEA metabolism in hair follicles may be linked to hair loss in balding men.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Bone mineral and minocycline boost bone cell growth, aiding healing.